Jessica A Powell

Title: Jessica A. Powell: Retina-Disease Patent

Introduction

Jessica A. Powell is an inventor associated with San Carlos, California, and Alkahest, Inc. Her patent work concerns approaches to treating retina-associated diseases, including wet age-related macular degeneration.

Latest Patents

Powell is associated with 1 patent, titled “Methods of Improving Retina-Associated Disease Outcome Using CCR3-Inhibitors.” The disclosure describes administering a CCR3 inhibitory agent before an anti-VEGF agent, then giving subsequent anti-VEGF doses less frequently than the recommended schedule. It also describes treating a retina-associated disease with an anti-VEGF agent at a reduced frequency in a subject previously treated with a CCR3 inhibitory agent.

Career Highlights

Powell’s listed invention focuses on potentially reducing the frequency of anti-VEGF treatment for patients with wet age-related macular degeneration and other retina-associated diseases. The patent disclosure presents a treatment sequence involving CCR3 inhibition followed by anti-VEGF therapy.

Collaborations

Powell’s listed company affiliation is Alkahest, Inc. Her named coworkers include Bartosz Sikorski and Erin McCaskill Newman.

Conclusion

Jessica A. Powell’s patent work at Alkahest, Inc. centers on a proposed CCR3-inhibitor approach intended to support less frequent anti-VEGF dosing for retina-associated diseases.